Personalized neurometabolic signature predicts seizure outcomes of laser ablation in mesial temporal lobe epilepsy.

Commun Med (Lond) · 2025 · PMC12635162 · PMID 41266775

Europe PMC DOI

hedged sentence

0.3400

closest p · 6.8× alpha

0.3400

boldest claim

The sentences

did not reach statistical significanceP = 0.34not close (p > 0.1)

Importantly, seizure outcomes differed significantly between subgroups dichotomized by this threshold (Pearson χ2 = 10.16, P = 0.001), whereas the RCS-derived inflection point of 58.65% did not reach statistical significance (Pearson χ2 = 0.92, P = 0.34; Fig. 3D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.